Cas:89469-44-3 4-(methanesulfonamido)-2-methoxybenzoic acid manufacturer & supplier

We serve Chemical Name:4-(methanesulfonamido)-2-methoxybenzoic acid CAS:89469-44-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(methanesulfonamido)-2-methoxybenzoic acid

Chemical Name:4-(methanesulfonamido)-2-methoxybenzoic acid
CAS.NO:89469-44-3
Synonyms:4-methanesulfonylamino-2-methoxybenzoic acid;2-methoxy-4-methanesulfonylaminobenzoic acid;2-METHOXY-4-[(METHYLSULFONYL)AMINO]BENZOIC ACID;Benzoic acid,2-methoxy-4-[(methylsulfonyl)amino];AmbkkkkK74
Molecular Formula:C9H11NO5S
Molecular Weight:245.25200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:101.08000
Exact Mass:245.03600
LogP:1.91870

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-methanesulfonylamino-2-methoxybenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AmbkkkkK74 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methoxy-4-methanesulfonylaminobenzoic acid Use and application,2-METHOXY-4-[(METHYLSULFONYL)AMINO]BENZOIC ACID technical grade,usp/ep/jp grade.


Related News: François-Henri Boissel, CEO of NOVA, commented: “Grégoire is an industry trail blazer with over two decades of experience in innovation, product strategy and digital entrepreneurship. 2-Isopropyl-1-methyl-1H-benzimidazole manufacturers In one of the patients, the viral vector was not present in the cancer cells, and in the other patient it was present at a site (VAMP4) that does not appear to be involved in cancer development. 6-(2-hydroxyethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine-3-carbonitrile suppliers However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. 1-(5-bromo-2-hydroxyphenyl)-3-(diethylamino)prop-2-en-1-one vendor & factory A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. ,François-Henri Boissel, CEO of NOVA, commented: “Grégoire is an industry trail blazer with over two decades of experience in innovation, product strategy and digital entrepreneurship.